scholarly journals Predicting Lung Cancer Survival Using Probabilistic Reclassification of TNM Editions With a Bayesian Network

2020 ◽  
pp. 436-443
Author(s):  
Melle S. Sieswerda ◽  
Inigo Bermejo ◽  
Gijs Geleijnse ◽  
Mieke J. Aarts ◽  
Valery E.P.P. Lemmens ◽  
...  

PURPOSE The TNM classification system is used for prognosis, treatment, and research. Regular updates potentially break backward compatibility. Reclassification is not always possible, is labor intensive, or requires additional data. We developed a Bayesian network (BN) for reclassifying the 5th, 6th, and 7th editions of the TNM and predicting survival for non–small-cell lung cancer (NSCLC) without training data with known classifications in multiple editions. METHODS Data were obtained from the Netherlands Cancer Registry (n = 146,084). A BN was designed with nodes for TNM edition and survival, and a group of nodes was designed for all TNM editions, with a group for edition 7 only. Before learning conditional probabilities, priors for relations between the groups were manually specified after analysis of changes between editions. For performance evaluation only, part of the 7th edition test data were manually reclassified. Performance was evaluated using sensitivity, specificity, and accuracy. Two-year survival was evaluated with the receiver operating characteristic area under the curve (AUC), and model calibration was visualized. RESULTS Manual reclassification of 7th to 6th edition stage group as ground truth for testing was impossible in 5.6% of the patients. Predicting 6th edition stage grouping using 7th edition data and vice versa resulted in average accuracies, sensitivities, and specificities between 0.85 and 0.99. The AUC for 2-year survival was 0.81. CONCLUSION We have successfully created a BN for reclassifying TNM stage grouping across TNM editions and predicting survival in NSCLC without knowing the true TNM classification in various editions in the training set. We suggest binary prediction of survival is less relevant than predicted probability and model calibration. For research, probabilities can be used for weighted reclassification.

2020 ◽  
Vol 19 ◽  
pp. 153303382095235
Author(s):  
Yaning Zhou ◽  
Yijun Guo ◽  
Qing Cui ◽  
Yun Dong ◽  
Xiaoyue Cai ◽  
...  

Objective: Lung cancer is often associated with hypercoagulability. Thromboelastography provides integrated information on clot formation in whole blood. This study explored the possible relationship between thromboelastography and lung cancer. Methods: Lung cancer was staged according to the Tumor, Node, and Metastasis (TNM) classification system. Thromboelastography parameters in different stages of disease were compared. The value of thromboelastography for stage prediction was determined by area under the receiver operating characteristic curve analysis. Results: A total of 182 patients diagnosed with lung cancer were included. Thromboelastography parameters, including kinetics time, α-angle, and maximum amplitude, differed significantly between patients with metastatic and limited lung cancers ( P < 0.05). Kinetics time was significantly reduced and maximum amplitude was significantly increased in patients with stage I and II compared with stage III and IV tumors ( P < 0.05). TNM stage was significantly negatively correlated with kinetics time ( r = −0.186), and significantly positively correlated with α-angle ( r = 0.151) and maximum amplitude ( r = 0.251) (both P < 0.05). The area under the curve for kinetics time in patients with stage I cancer was 0.637 ( P < 0.05) and that for α-angle in stage ≥ II was 0.623 ( P < 0.05). The areas under the curves for maximum amplitude in stage ≥ III and stage IV cancer were 0.650 and 0.605, respectively (both P < 0.05). Thromboelastography parameters were more closely associated with TNM stage in patients with lung adenocarcinoma than in the whole lung cancer population. Conclusion: This study identified the diagnostic value of thromboelastography parameters for determining tumor stage in patients with lung cancer. Thromboelastography can be used as an independent predictive parameter for lung cancer severity.


2008 ◽  
Vol 3 (12) ◽  
pp. 1384-1390 ◽  
Author(s):  
William D. Travis ◽  
Elisabeth Brambilla ◽  
Ramon Rami-Porta ◽  
Eric Vallières ◽  
Masahiro Tsuboi ◽  
...  

2014 ◽  
Vol 140 (7) ◽  
pp. 1189-1195 ◽  
Author(s):  
Jia Wang ◽  
Nan Wu ◽  
Qingfeng Zheng ◽  
Yuan Feng ◽  
Shi Yan ◽  
...  

2020 ◽  
Vol 5 (1-2) ◽  
pp. 1-9
Author(s):  
Samantha Taber ◽  
Joachim Pfannschmidt

AbstractObjectivesThe updated 8th edition of the tumor, node, metastases (TNM) classification system for non-small cell lung cancer (NSCLC) attempts to improve on the previous 7th edition in predicting outcomes and guiding management decisions. This study sought to determine whether the 8th edition was more accurate in predicting long-term survival in a European population of surgically treated NSCLC patients.MethodsWe scanned the archives of the Heckeshorn Lung Clinic for patients with preoperative clinical stages of IIIA or lower (based on the 7th edition), who received surgery for NSCLC between 2009 and 2014. We used pathologists’ reports and data on tumor size and location to reassign tumor stages according to the 8th edition. We then analyzed stage specific survival and compared the accuracy of the two systems in predicting long-term survival. We excluded patients with neoadjuvant treatment, incomplete follow-up data, tumor histologies other than NSCLC, or death within 30 days of surgery.ResultsThe final analysis included 1,013 patients. Overall five-year survival was 47.3%. The median overall survival (OS) was 63 months (range 1–222), and the median disease-free survival (DFS) was 50 months (0–122). The median follow-up time for non-censored patients was 84 months (range 60–122).ConclusionsWe found significant survival differences between the newly defined stages 1A1, 1A2 and 1A3 (previously 1A). We also found that the 8th edition of TMN classification was a significantly better predictor of long-term survival, compared to the 7th edition.


2021 ◽  
Vol 16 (4) ◽  
pp. S712-S713
Author(s):  
M.R.R. Islam ◽  
A.T.M.K. Hasan ◽  
N. Khatun ◽  
I. Ridi ◽  
N. Ishrat ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document